Enhanced expression of p210BCR/ABL and aberrant expression of Zfp423/ZNF423 induce blast crisis of chronic myelogenous leukemia

Blood

Volumn 113, Issue 19, 2009, Pages 4702-4710

  Miyazaki, Kazuko ^a   Yamasaki, Norimasa ^a   Oda, Hideaki ^b   Kuwata, Takeshi ^c   Kanno, Yohei ^d   Miyazaki, Masaki ^e   Komeno, Yukiko ^f   Kitaura, Jiro ^f   Honda, Zen Ichiro ^g   Warming, Søren ^h   Jenkins, Nancy A ⁱ   Copeland, Neal G ⁱ   Kitamura, Toshio ^f   Nakamura, Takuro ^d   Honda, Hiroaki ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^c NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^d CANCER INSTITUTE   (Japan)

^e HIROSHIMA UNIVERSITY   (Japan)

^f UNIVERSITY OF TOKYO   (Japan)

^g UNIVERSITY OF TOKYO   (Japan)

^h GENENTECH INC   (United States)

ⁱ INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ZFP423; TRANSCRIPTION FACTOR ZNF423; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; EBFAZ PROTEIN, MOUSE; MESSENGER RNA; SMALL INTERFERING RNA; ZINC FINGER PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLAST CELL CRISIS; BONE MARROW CELL; CELL GROWTH; CHRONIC MYELOID LEUKEMIA; COLONY FORMING UNIT; COMMON VIRAL INTEGRATION SITE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCATION; GENETIC TRANSDUCTION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; INVERSE POLYMERASE CHAIN REACTION; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TRANSGENIC MOUSE; ANIMAL; B LYMPHOCYTE; BONE MARROW TRANSPLANTATION; CELL PROLIFERATION; CLONOGENIC ASSAY; DRUG ANTAGONISM; FLOW CYTOMETRY; GENE REARRANGEMENT; GENETICS; METABOLISM; MOUSE MUTANT; NORTHERN BLOTTING; PATHOLOGY; PHENOTYPE; PHYSIOLOGY; RETROVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; SURVIVAL RATE; WESTERN BLOTTING;

ANIMALS; B-LYMPHOCYTES; BLAST CRISIS; BLOTTING, NORTHERN; BLOTTING, SOUTHERN; BLOTTING, WESTERN; BONE MARROW TRANSPLANTATION; CELL PROLIFERATION; COLONY-FORMING UNITS ASSAY; DNA-BINDING PROTEINS; FEMALE; FLOW CYTOMETRY; FUSION PROTEINS, BCR-ABL; GENE EXPRESSION REGULATION, LEUKEMIC; GENE REARRANGEMENT; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MALE; MICE; MICE, KNOCKOUT; PHENOTYPE; RETROVIRIDAE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SURVIVAL RATE; TRANSCRIPTION FACTORS; ZINC FINGERS;

EID: 66549101521     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2007-05-088724     Document Type: Article

References (56)

1. Deininger MWN, Goldman JM, Melo JV. The molecular biology of chronic myeloid leukemia. Blood. 2000;96:3343-3356. (Pubitemid 30836310)
2. Ren R. Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia. Nat Rev Cancer. 2005;5:172-183. (Pubitemid 40314949)
3. Rowley JD. A new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Giemsa staining. Nature. 1973;243:290-293.
4. de Klein A, van Kessel AG, Grosveld G, et al. A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia. Nature. 1982;300:765-767. (Pubitemid 13224358)
5. Groffen J, Stephenson JR, Heisterkamp N, deKlein A, Bartram CR, Grosveld G. Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell. 1984;36:93-99.
6. Shtivelman E, Lifshitz B, Gale RP, Canaani E. Fused transcript of abl and bcr genes in chronic myelogenous leukaemia. Nature. 1985;315:550-554. (Pubitemid 15021190)
7. Konopka JB, Watanabe SM, Witte ON. An alternation of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity. Cell. 1984;37:1035-1042.
8. Calabretta B, Perrotti D. The biology of CML blast crisis. Blood. 2004;103:4010-4022.
9. Pear WS, Miller JP, Xu L, et al. Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow. Blood. 1998;92:3780-3792. (Pubitemid 28525205)
10. Zhang X, Ren R. Bcr-Abl efficiently induces a myeloproliferative disease and production of excess interleukin-3 and granulocyte-macrophage colony-stimulating factor in mice: a novel model for chronic myelogenous leukemia. Blood. 1998;92:3829-3840. (Pubitemid 28525209)
11. Li S, Ilaria RLJ, Million RP, Daley GQ, Van Etten RA. The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity. J Exp Med. 1999;189:1399-11342 (Pubitemid 29227526)
12. Honda H, Fujii T, Takatoku M, et al. Expression of p210bcr/abl by metallothionein promoter induced T-cell leukemia in transgenic mice. Blood. 1995;85:2853-2861.
13. Voncken JW, Kaartinen V, Pattengale PK, Germeraad WTV, Groffen J, Heisterkamp N. BCR/ABL p210 and p190 cause distinct leukemia in transgenic mice. Blood. 1995;86:4603-4611.
14. Honda H, Oda H, Suzuki T, et al. Development of acute lymphoblastic leukemia and myeloproliferative disorder in transgenic mice expressing p210bcr/abl: a novel transgenic model for human Ph1-positive leukemias. Blood. 1998;91:2067-2075. (Pubitemid 28185510)
15. Huettner CS, Zhang P, Van Etten RA, Tenen DG. Reversibility of acute B-cell leukaemia induced by BCR-ABL1. Nat Genet. 2000;24:57-60. (Pubitemid 30041421)
16. Huettner CS, Koschmieder S, Iwasaki H, et al. Inducible expression of BCR/ABL using human CD34 regulatory elements results in a megakaryocytic myeloproliferative syndrome. Blood. 2003;102:3363-3370. (Pubitemid 37314779)
17. Koschmieder S, Gottgens B, Zhang P, et al. Inducible chronic phase of myeloid leukemia with expansion of hematopoietic stem cells in a transgenic model of BCR-ABL leukemogenesis. Blood. 2005;105:324-334. (Pubitemid 40053100)
18. Honda H, Yamashita Y, Ozawa K, HM. Cloning and characterization of mouse tec promoter. Biochem Biophys Res Commun. 1996;223:422-426.
19. Honda H, Ozawa K, Yazaki Y, Hirai H. Identification of PU. 1 and Sp1 as essential transcriptional factors for the promoter activity of mouse tec gene. Biochem Biophys Res Comm. 1997;234:376-381. (Pubitemid 27243911)
20. Honda H, Ushijima T, Wakazono K, et al. Acquired loss of p53 induces blastic transformation in p210bcr/abl-expressing hematopoietic cells: a transgenic study for blast crisis of human CML. Blood. 2000;95:1144-1150. (Pubitemid 30099819)
21. Niki M, Cristofano DA, Zhao M, et al. Role of Dok-1 and Dok-2 in leukemia suppression. J Exp Med. 2004;200:1689-1695. (Pubitemid 40094192)
22. Li J, Shen H, Himmel KL, et al. Leukaemia disease genes: large-scale cloning and pathway predictions. Nat Genet. 1999;23:348-353. (Pubitemid 29526436)
23. Akagi K, Suzuki T, Stephens RM, Jenkins NA, Copeland NG. RTCGD: retroviral tagged cancer gene database. Nucleic Acids Res. 2004;32(database issue):D523-D527. (Pubitemid 38081713)
24. Turcotte K, Gauthier S, Tuite A, Mullick A, Malo D, Gros P. A mutation in the Icsbp1 gene causes susceptibility to infection and a chronic myeloid leukemia-like syndrome in BXH-2 mice. J Exp Med. 2005;201:881-890. (Pubitemid 40524458)
25. Miyazaki K, Kawamoto T, Tanimoto K, Nishiyama M, Honda H, Kato Y. Identification of functional hypoxia response elements in the promoter region of the DEC1 and DEC2 genes. J Biol Chem. 2002;277:47014-47021. (Pubitemid 36159208)
26. University of Colombo School of Computing. UCSC Genome Browser. http://genome.ucsc.edu. Accessed January 2009.
27. National Cancer Institute-Frederick. Mouse Retrovirus Tagged Cancer Gene Database. http://rtcgd.abcc.ncifcrf.gov. Accessed January 2009.
28. Kitamura T, Koshino Y, Shibata F, et al. Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics. Exp Hematol. 2003;31:1007-1014. (Pubitemid 37329742)
29. Morita S, Kojima T, Kitamura T. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther. 2000;7:1063-1066. (Pubitemid 30398356)
30. Jin G, Yamazaki Y, Takuwa M, et al. Trib1 and Evi1 cooperate with Hoxa and Meis1 in myeloid leukemogenesis. Blood. 2007;109:3998-4005. (Pubitemid 46641753)
31. Kono H, Kyogoku C, Suzuki T, et al. FcgammaRIIB Ile232Thr transmembrane polymorphism associated with human systemic lupus erythematosus decreases affinity to lipid rafts and attenuates inhibitory effects on B cell receptor signaling. Hum Mol Genet. 2005;14:2881-2892. (Pubitemid 41418793)
32. Harada H, Harada Y, Tanaka H, Kimura A, Inaba T. Implications of somatic mutations in the AML1 gene in radiation-associated and therapy-related myelodysplastic syndrome/acute myeloid leukemia. Blood. 2003;101:673-680. (Pubitemid 36077592)
33. Warming S, Suzuki T, Yamaguchi TP, Jenkins NA, Copeland NG. Early B-cell factor-associated zinc-finger gene is a frequent target of retroviral integration in murine B-cell lymphomas. Oncogene. 2004;23:2727-2731. (Pubitemid 38586326)
34. Warming S, Liu P, Suzuki T, et al. Evi3, a common retroviral integration site in murine B-cell lymphoma, encodes an EBFAZ-related Kruppel-like zinc finger protein. Blood. 2003;101:1934-1940. (Pubitemid 36237596)
35. Sanuki S, Hamanaka S, Kaneko S, et al. A new red fluorescent protein that allows efficient marking of murine hematopoietic stem cells. J Gene Med. 2008;10:965-971.
36. Pane F, Intrieri M, Quintarelli C, Izzo B, Muccioli GC, Salvatore F. BCR/ABL genes and leukemic phenotype: from molecular mechanisms to clinical correlations. Oncogene. 2002;21:8652-8667. (Pubitemid 36084197)
37. Iwasaki M, Kuwata T, Yamazaki Y, et al. Identification of cooperative genes for NUP98-HOXA9 in myeloid leukemogenesis using a mouse model. Blood. 2005;105:784-793. (Pubitemid 40070766)
38. Yanagida M, Osato M, Yamashita N, et al. Increased dosage of Runx1/AML1 acts as a positive modulator of myeloid leukemogenesis in BXH2 mice. Oncogene. 2005;24:4477-4485. (Pubitemid 41032611)
39. Yamashita N, Osato M, Huang L, et al. Haploinsufficiency of Runx1/AML1 promotes myeloid features and leukaemogenesis in BXH2 mice. Br J Haematol. 2005;131:495-507. (Pubitemid 43899649)
40. Mizuno T, Yamasaki N, Miyazaki K, et al. Overexpression/enhanced kinase activity of BCR/ABL and altered expression of Notch1 induced acute leukemia in p210BCR/ABL transgenic mice. Oncogene. 2008;27:3465-3474. (Pubitemid 351769317)
41. Tien HF, Chuang SM, Wang CH, et al. Chromosomal characteristics of Ph-positive chronic myelogenous leukemia in transformation: a study of 23 Chinese patients in Taiwan. Cancer Genet Cytogenet. 1989;39:89-97.
42. Griesshammer M, Heinze B, Bangerter M, Heimpel H, Fliedner TM. Karyotype abnormalities and their clinical significance in blast crisis of chronic myeloid leukemia. J Mol Med. 1997;75:836-838. (Pubitemid 27511559)
43. Tsai RY, Reed RR. Cloning and functional characterization of Roaz, a zinc finger protein that interacts with O/E-1 to regulate gene expression: implications for olfactory neuronal development. J Neurosci. 1997;17:4159-4169.
44. Tsai RY, Reed RR. Identification of DNA recognition sequences and protein interaction domains of the multiple-Zn-finger protein Roaz. Mol Cell Biol. 1998;18:6447-6456.
45. Hata A, Seoane J, Lagna G, Montalvo E, Hemmati-Brivanlou A, Massague J. OAZ uses distinct DNA- and protein-binding zinc fingers in separate BMP-Smad and Olf signaling pathways. Cell. 2000;100:229-240. (Pubitemid 30064911)
46. Warming S, Rachel RA, Jenkins NA, Copeland NG. Zfp423 is required for normal cerebellar development. Mol Cell Biol. 2006;26:6913-6922. (Pubitemid 44387640)
47. Lauberth SM, Rauchman MA. Conserved 12-amino acid motif in Sall1 recruits the nucleosome remodeling and deacetylase corepressor complex. J Biol Chem. 2006;281:23922-23931.
48. Hentges KE, Weiser KC, Schountz T, Woodward LS, Morse HC, Justice MJ. Evi3, a zinc-finger protein related to EBFAZ, regulates EBF activity in B-cell leukemia. Oncogene. 2005;24:1220-1230. (Pubitemid 40313923)
49. Bond HM, Mesuraca M, Amodio N, et al. Early hematopoietic zinc finger protein-zinc finger protein 521: a candidate regulator of diverse immature cells. Int J Biochem Cell Biol. 2008;40:848-854. (Pubitemid 351329659)
50. Wu J, Song Y, Bakker AB, et al. An activating immunoreceptor complex formed by NKG2D and DAP10. Science. 1999;285:730-732. (Pubitemid 129505075)
51. Chang C, Dietrich J, Harpur AG, et al. Cutting edge: KAP10, a novel transmembrane adapter protein genetically linked to DAP12 but with unique signaling properties. J Immunol. 1999;163:4651-4654. (Pubitemid 29501224)
52. Mehta DS, Wurster AL, Grusby MJ. Biology of IL-21 and the IL-21 receptor. Immunol Rev. 2004;202:84-95.
53. Leonard WJ, Spolski R. Interleukin-21: a modulator of lymphoid proliferation, apoptosis and differentiation. Nat Rev Immunol. 2005;5:688-698. (Pubitemid 43086171)
54. Wellcome Trust Sanger. Cancer Gene Census. http://www.sanger.ac.uk/ genetics/CGP/Census. Accessed -.
55. Yuki Y, Imoto I, Imaizumi M, et al. Identification of a novel fusion gene in a pre-B acute lymphoblastic leukemia with t(1;19)(q23;p13). Cancer Sci. 2004;95:503-507. (Pubitemid 38832699)
56. Du Y, Spence SE, Jenkins NA, Copeland NG. Cooperating cancer-gene identification through oncogenic-retrovirus-induced insertional mutagenesis. Blood. 2005;106:2498-2505. (Pubitemid 41510825)